Bladder function of patients with Parkinson's disease

Area of Science:

• Neurology
• Urology
• Neuroscience

Background:

• Parkinson's disease (PD) frequently causes significant bladder dysfunction, primarily overactive bladder (urinary urgency/frequency).
• The underlying pathophysiology involves altered brain-bladder communication, specifically within the frontal-basal ganglia D1 dopaminergic circuit that regulates the micturition reflex.
• Understanding PD-related bladder dysfunction is crucial for differential diagnosis, as it differs from conditions like multiple system atrophy.

Purpose of the Study:

• To summarize the altered brain-bladder relationship in Parkinson's disease.
• To review current and emerging treatment strategies for bladder dysfunction in PD patients.
• To highlight the importance of tailored therapies for improving patient quality of life.

Main Methods:

• Review of existing literature on Parkinson's disease and lower urinary tract symptoms.
• Analysis of the neurobiological mechanisms underlying bladder control in PD.
• Evaluation of pharmacological and non-pharmacological treatment options.

Main Results:

• The majority of Parkinson's disease patients exhibit overactive bladder with minimal post-void residual urine.
• Levodopa's effect on bladder function in PD is variable, often necessitating add-on therapies.
• Anticholinergics are first-line, with caution regarding cognitive side effects in the elderly; second-line options include serotonergics and desmopressin.

Conclusions:

• Altered dopaminergic pathways in Parkinson's disease disrupt normal bladder control.
• A multi-faceted treatment approach, including medications and advanced therapies like deep brain stimulation and botulinum toxin, is often required.
• Effective management of bladder dysfunction is key to enhancing the overall quality of life for Parkinson's disease patients.